A 74-year-old woman develops haemolytic anaemia and stress cardiomyopathy after a tick bite, highlighting a rare cardiac ...

Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for ...

The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

With India witnessing a quiet explosion in heart failure cases, many striking working-age adults, STAR Hospitals has launched ...

"We are thrilled to see the C-MIC II results published in the European Journal of Heart Failure ," said John Brumfield, CEO of Berlin Heals "These findings support our mission to develop breakthrough, ...

A new study published in the journal of BMC Nephrology showed that hemodialysis patients with end-stage renal disease (ESRD) ...

Toddler, Ezra, has been given a new chance of life after he received a heart transplant. Now his family want to spread ...